In situ self-assembly—the in situ formation of complex materials via biochemical reactions of
monomers—has enhanced the efficacy of drug delivery for cancer therapy and imaging. So …

Light has profoundly impacted modern medicine and healthcare, with numerous
luminescent agents and imaging techniques currently being used to assess health and treat …

Afterglow luminescence (long persistent luminescence) holds great potential for
nonbackground molecular imaging. However, current afterglow probes are mainly …

The responses of patients to tumor therapies vary due to tumor heterogeneity. Tumor
stratification has been attracting increasing attention for accurately distinguishing between …

Photoluminescence (PL) imaging has become a fundamental tool in disease diagnosis,
therapeutic evaluation, and surgical navigation applications. However, it remains a big …

Early diagnosis of renal fibrosis is crucially significant on account of its worldwide prevalent
tendency. Optical imaging in the near‐infrared window has been recognized as an …

Multimodal imaging, which harnesses two or more imaging modalities to produce
complementary anatomical and molecular information of a living subject, has become as a …

Gastric cancer (GC) represents a significant burden of cancer-related mortality worldwide,
underscoring an urgent need for the development of early detection strategies and precise …

Afterglow materials-based biological imaging has promising application prospects, due to
negligible background. However, currently available afterglow materials mainly include …

Near‐infrared (NIR) chemiluminescence imaging holds potential for sensitive imaging of
cancer due to its low background; however, few NIR chemiluminophores are available …